Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation
about
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activityEngineering a beta-helical D,L-peptide for folding in polar media.Enantioselective Synthesis of α-Bromonitroalkanes for Umpolung Amide Synthesis: Preparation of tert-Butyl ((1R)-1-(4-(benzyloxy)phenyl)-2-bromo-2-nitroethyl)carbamateHeterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli.Advances in MRSA drug discovery: where are we and where do we need to be?Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.New antibacterial agents: patent applications published in 2011.Total synthesis of the antiviral peptide antibiotic feglymycin.Silyl imine electrophiles in enantioselective catalysis: a Rosetta Stone for peptide homologation, enabling diverse N-protected aryl glycines from aldehydes in three steps.Total synthesis of feglymycin based on a linear/convergent hybrid approach using micro-flow amide bond formation.In Situ-Generated Glycinyl Chloroaminals for a One-Pot Synthesis of Non-proteinogenic α-Amino Esters.Alanine scan of the peptide antibiotic feglymycin: assessment of amino acid side chains contributing to antimicrobial activity.Genome-based classification of micromonosporae with a focus on their biotechnological and ecological potential.Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism.Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway.
P2860
Q27640413-2B814A32-EFE4-4174-8F36-6EDC749226DBQ33507119-A6929613-D016-4D80-B0B0-04235B01A575Q33752179-31E41A77-2D65-4DB6-8300-0325D7D96696Q34433222-D87B35D9-6370-4941-875D-8FFF38223938Q37112508-183FBA0F-A06C-4C6D-BD34-845864E244B8Q38137920-02373985-2254-4D61-B479-B855B7FC11F5Q38172657-C1B22820-25BA-4E27-997D-ABAC747322E9Q39889462-4926389D-AF05-4056-9C11-59965231FF62Q40759490-50C14340-25CD-4487-AF80-BB540D4159ECQ41826662-5BC6B897-EF1D-4BE7-84BF-45F59BB0BB91Q45894002-0394E43A-3A34-4D59-B0B1-9715E4FF0726Q46453851-BFEE55EA-7736-46F2-8774-3FB71682A8D7Q48262869-EC7F6B98-1EE9-44F2-866D-60A0FB05422CQ52861046-65026497-85FF-424F-8E26-51816ECB7915Q52895876-B02502EC-B05E-4B53-BC05-F556E0F820AA
P2860
Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@ast
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@en
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@nl
type
label
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@ast
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@en
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@nl
prefLabel
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@ast
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@en
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@nl
P2093
P1476
Feglymycin, a novel inhibitor ...... tion and structure elucidation
@en
P2093
P304
P356
10.7164/ANTIBIOTICS.52.374
P407
P577
1999-04-01T00:00:00Z